Catalent Pharma Solutions to Host Workshop at RDD Europe 2009
on: May 15, 2009, 5:07 am
Author: Dan Dunlop / Jennings
Triangle Park, NC – May 14, 2009 – Two Catalent scientists,
Dr. Tom Feinberg, director of structural chemistry services, and
Dr. Craig Davies-Cutting, director of research and development,
will host a 45-minute interactive workshop at RDD Europe 2009.
The conference is designed for academic, industrial and regulatory
scientists involved in the development, investigation, preparation
and delivery of existing and new therapeutic entities by inhalation.
It takes place in Lisbon, Portugal, May 19-22, 2009.
Catalent sponsored workshop is titled “Formulation and Leachables
Considerations in Component Selection for Inhalation Drug Products.”
Workshop abstract: Although the range of inhalation delivery devices
and components has increased, the rate of new product approvals
has not. One explanation is the need to thoroughly explore hardware
and formulation compatibility and performance during product development.
Additionally, global regulatory expectations have been raised
since the publication and dissemination of the Product Quality
Research Institute’s Safety Thresholds and Best Practices
for Extractables and Leachables in Orally Inhaled and Nasal Drug
Products. This workshop outlines an optimized approach for formulation-device
combination screening and selection, and discusses the impact
of leachables and materials characterization methods selection
on the testing timeline.
Feinberg and Dr. Davies-Cutting are members of Catalent’s
Respiratory, Analytical and Biotechnology group, based in North
Carolina’s Research Triangle Park.
Headquartered in Somerset, New Jersey, Catalent Pharma Solutions
is a leading provider of advanced dose form and packaging technologies,
and development, manufacturing and packaging services for pharmaceutical,
biotechnology and consumer healthcare companies in nearly 100
countries. Catalent applies its local market expertise and technical
creativity to advance treatments, change markets and enhance patient
outcomes. Catalent employs approximately 9,100 at more than 30
facilities worldwide and in fiscal 2008 generated more than $1.8
billion of annual revenue. For more information, visit www.catalent.com.
Contact Details: Dan Dunlop
104-A North Elliott Road
Chapel Hill, NC 27514